| scholarly article | Q13442814 |
| P50 | author | Anette Larsson | Q58665113 |
| Rydvikha Govender | Q91758935 | ||
| P2093 | author name string | Staffan Folestad | |
| Susanna Abrahmsén-Alami | |||
| P2860 | cites work | Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 |
| Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine | Q27692687 | ||
| The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome | Q28071938 | ||
| The genetic basis of variability in drug responses | Q34741545 | ||
| Amorphous solid dispersions: Rational selection of a manufacturing process | Q35908887 | ||
| Parsing interindividual drug variability: an emerging role for systems pharmacology | Q36417380 | ||
| Evaluation of amorphous solid dispersion properties using thermal analysis techniques. | Q37917883 | ||
| Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation | Q38544558 | ||
| 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems | Q38693431 | ||
| Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century | Q38737132 | ||
| Personalized Drug Dosage - Closing the Loop | Q40956598 | ||
| A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers | Q44008108 | ||
| A New Method of Constructing Drug-Polymer Temperature-Composition Phase Diagram Relevant to the Hot-Melt Extrusion Platform | Q47368858 | ||
| Melt extrusion with poorly soluble drugs - An integrated review. | Q50161058 | ||
| Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. | Q50267056 | ||
| Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. | Q51320712 | ||
| Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen. | Q51565581 | ||
| Tailored on demand anti-coagulant dosing: an in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms. | Q52577046 | ||
| On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing. | Q52655589 | ||
| Tailoring supersaturation from amorphous solid dispersions. | Q53410930 | ||
| Real time Raman imaging to understand dissolution performance of amorphous solid dispersions | Q57162940 | ||
| Influence of Different Polymers on the Crystallization Tendency of Molecularly Dispersed Amorphous Felodipine | Q57343249 | ||
| A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems | Q57351431 | ||
| From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets | Q57462721 | ||
| Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend | Q80854923 | ||
| Fused-filament 3D printing (3DP) for fabrication of tablets | Q85666237 | ||
| Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing | Q86145573 | ||
| 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets | Q86251570 | ||
| Effect of geometry on drug release from 3D printed tablets | Q87230321 | ||
| Cellulose based polymers in development of amorphous solid dispersions | Q89910048 | ||
| 'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures | Q90720173 | ||
| Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry | Q90881173 | ||
| Comparison of fused-filament fabrication to direct compression and injection molding in the manufacture of oral tablets | Q91120971 | ||
| Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling | Q93174185 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 9 | |
| P577 | publication date | 2019-12-17 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | High Content Solid Dispersions for Dose Window Extension: A Basis for Design Flexibility in Fused Deposition Modelling | |
| P478 | volume | 37 |
Search more.